Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pluri Inc. Board/Management Information 2021

Jul 19, 2021

6990_rns_2021-07-19_fd676b9a-4c87-428e-ae17-966135e8b4e8.htm

Board/Management Information

Open in viewer

Opens in your device viewer

8k - Appointment of new Directors false

�������� ��������� ���� 2 380
PLURISTEM THERAPEUTICS INC
Corporation no: C12337-2001 8543
- - -
Israel Securities Authority Tel Aviv Stock Exchange C002 ( Public ) Reported via MAGNA: 19/07/2021
www.isa.gov.il www.tase.co.il Reference: 2021-02-118884 Time of broadcast: 14:36 14:27:14

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on8k - Appointment of new Directors

ea144418-8k_pluristemEDGAR1_Bannerless_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NASDAQ CM Date of revision of form structure: 15/06/2021
Address: Matam Park 5 , Haifa 31905   ISRAEL , Tel: 074-7107171 , Fax: 074-7107172
E-mail address: [email protected]   Company site: www.pluristem.com
Previous names of reporting entity:
Name of the Signatory: Yanay Yaacov Position of Signatory in the reporting corporation: Chief Executive Officer, Director Name of Employer Company:
Address: Matam Park 5 , Haifa 31905 Telephone: 074-7107171 Facsimile: 074-7108673 E-mail: [email protected] 1